Study finds loss of RBFOX2 protein promotes pancreatic cancer metastasis through effects on cytoskeletal remodeling
Pancreatic cancer presents a challenging prognosis, marked by a five-year overall survival rate of merely 12.5%. Diagnosis frequently occurs at an advanced stage, characterized by metastasis to distant sites. The intricate ...
Jan 11, 2024
0
29